NCT07038005 2026-02-09
A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
Clinical Trials
9 trialsNCT06877650 2026-01-29
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Shanghai JMT-Bio Inc.
Phase 1/2 Recruiting
NCT07016490 2026-01-28
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT07043751 2026-01-21
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT07032298 2025-07-25
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT05868876 2025-03-03
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
Akeso
Phase 1 Recruiting
NCT05991583 2025-01-17
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Recruiting
NCT05877924 2024-03-26
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
NovaRock Biotherapeutics, Ltd
Phase 1 Recruiting
NCT06223841 2024-02-20
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Recruiting